featured
Fluorouracil and Dose-Dense Adjuvant Chemotherapy in Patients With Early-Stage Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial
Lancet Oncol 2022 Nov 09;[EPub Ahead of Print], L Del Mastro, F Poggio, E Blondeaux, S De Placido, M Giuliano, V Forestieri, M De Laurentiis, A Gravina, G Bisagni, A Rimanti, A Turletti, C Nisticò, A Vaccaro, F Cognetti, A Fabi, S Gasparro, O Garrone, MG Alicicco, Y Urracci, M Mansutti, P Poletti, P Correale, C Bighin, F Puglisi, F Montemurro, G Colantuoni, M Lambertini, L BoniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.